Pricing Log in Create free account

ABVC BioPharma, Inc. (ABVC) vs Atossa Therapeutics, Inc. (ATOS)

ABVC BioPharma, Inc. and Atossa Therapeutics, Inc. are both Biotechnology companies. ABVC BioPharma, Inc. and Atossa Therapeutics, Inc. are of similar size ($26.4M and $24.9M). ABVC BioPharma, Inc. grew revenue faster over the last twelve months: 5,035.4% against −93.7%. Across the 13 metrics below, ABVC BioPharma, Inc. leads on 10 and Atossa Therapeutics, Inc. on 3.

Valuation

Metric ABVC ATOS Biotechnology median
P/E n/m n/m 8.50
P/S 18.38 646.51 9.71
P/B 1.95 0.97 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.01 0.64
EV/Sales 19.64 (6.95) 9.21
Earnings yield (36.91%) (150.60%) (33.15%)
Free cash flow yield (11.33%) (138.09%) (25.50%)

Profitability

Metric ABVC ATOS Biotechnology median
Gross margin 99.97% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (65.32%) (89.23%) (56.36%)
Return on assets (39.88%) (77.91%) (48.04%)
Return on invested capital (33.45%) (3,918.83%) 0.00%

Growth

Metric ABVC ATOS Biotechnology median
Revenue growth (TTM) 5,035.43% (93.66%) 6.02%
EPS growth (last fiscal year) 7.14% (34.73%) 30.26%
Revenue growth, 5-year CAGR (6.20%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABVC ATOS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.07 5.69 4.72
Net debt to EBITDA 0.21 1.12 0.96

Dividend

Metric ABVC ATOS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABVC ATOS Biotechnology median
Market cap 24.89m 26.44m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack